<DOC>
	<DOCNO>NCT00903409</DOCNO>
	<brief_summary>In previous trial ( LOV111858/OM6 ) , subject receive double-blind fashion either 4 g/day Lovaza速 ( omega-3-ethyl ester ) [ formerly know Omacor ] co-administered simvastatin 40 mg/day placebo co-administered simvastatin 40 mg/day 8 week . This extension trial , LOV111818/OM6X assess continue efficacy safety Lovaza速 ( omega-3-ethyl ester ) co-administered simvastatin 40 mg vs. switch simvastatin plus placebo simvastatin plus Lovaza速 lower non-High Density Lipoprotein-Cholesterol ( non-HDL-C ) level 4 month ( primary endpoint ) additionally 12 24 month .</brief_summary>
	<brief_title>Open-Label Extension Randomized , Double-Blind , Placebo-Controlled Study Assess Efficacy Safety Lovaza速 Simvastatin Therapy Hypertriglyceridemic Subjects</brief_title>
	<detailed_description>Two study comprise OM6 Program . Study LOV111858/OM6 ( double-blind study ) outline NCT00246701 Study LOV111818/OM6X ( open-label extension ) outline post .</detailed_description>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>For LOV111818/OM6X Subjects include study meet relevant inclusion/exclusion criterion prior throughout doubleblind Study LOV111858/OM6 complete Study LOV111858/OM6 Week 8 . FYI entry criterion LOV111818/OM6 ( doubleblind study ) Men woman age 1879 year , inclusive Current therapy statin drug Triglyceride level 200 499 mg/dL Normally active good health basis medical history , brief physical examination , electrocardiogram , routine laboratory test Provide write informed consent authorization protect health information disclosure Sensitivity statin drug omega3 fatty acid Lipoprotein lipase impairment apo C2 deficiency type III hyperlipidemia Unexplained muscle pain weakness History pancreatitis Recent history certain heart , kidney , liver , lung , gastrointestinal disease , cancer ( except nonmelanoma skin cancer ) Poorly control diabetes , receive insulin therapy Pregnant lactating female . Women childbearing potential use medically approve method contraception . Use certain type hormone , anticonvulsant drug , immunologic drug , antibiotic , antifungal antiviral drug , cardiac drug Use warfarin ( Coumadin )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>High triglyceride</keyword>
	<keyword>Lovaza</keyword>
	<keyword>simvastatin</keyword>
	<keyword>omega-3-acid ethyl ester</keyword>
</DOC>